Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La Ciencia

6 trials Academic / non-commercial

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

0 Recruiting

5 Completed trials

1 Countries active

14 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III/IV

Phase IV

Phase III: 1 Phase II: 3 Phase III/IV: 1 Phase IV: 1

100%

5 of 5 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

PLITIDEPSIN 2 BARICITINIB 1 DORAVIRINE 1 EMTRICITABINE, TENOFOVIR ALAFENAMIDE 1 EMTRICITABINE, TENOFOVIR ALAFENAMIDE, BICTEGRAVIR 1 LAMIVUDINE 1 LAMIVUDINE, DORAVIRINE, TENOFOVIR DISOPROXIL 1

All trials

6 total

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post COVID-1… Not authorised

2023-504087-42-00 Phase III 1 country PLITIDEPSIN
Safety and Impact of Baricitinib on Cell Surivival Pathways, HIV-1 Reservoir and Inflamation in People With HIV-1 Ended

2024-520159-26-00 Phase II 1 country BARICITINIB
Phase II proof-of-concept, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of plitidepsin in adults w… Ended

2024-516378-31-00 Phase II 1 country PLITIDEPSIN
Impact of Doravirine in Liver Steatosis and Fibrosis in PLWH. A pilot, proof of concept study (DORALI Study) Ended

2023-504952-87-00 Phase IV 1 country DORAVIRINE; EMTRICITABINE, TENOFOVIR ALAFENAMIDE; EMTRICITABINE, TENOFOVIR ALAFE…
A single-center study to assess the effect of lamivudine (3TC) on cognitive impairment (alterations in thinking, learning, memory...) by the… Ended

2024-514330-20-00 Phase II 1 country LAMIVUDINE
Oral Alternative Antibiotics for Patients with Syphilis Ended

2024-514984-24-00 Phase III/IV 1 country

Showing 1–6 of 6 trials

← All sponsors A–Z